Guggenheim initiates coverage of Korsana Biosciences with Buy rating, $70 price target

Guggenheim initiated coverage on Korsana Biosciences's stock with a rating of Buy and a price target of $70.00.The price target implies an upside of 125.8% from the Sep 25 close of $31.Key takeaways from the analyst noteStrong Market Potential: Korsana Biosciences is positioned to capitalize on a m…